MedPath

Differential Diagnosis of Pulmonary Hypertension With Automated Image Analysis

Terminated
Conditions
Pulmonary Hypertension
Interventions
Radiation: Thoracic computed tomography
Registration Number
NCT04329312
Lead Sponsor
Medical University of Graz
Brief Summary

The aim of the study is to determine relevant morphologic parameters of the lung vasculature for the differentiation between different groups of patients with pulmonary hypertension (PH) by thoracic computer tomography (CT). In this pilot study patients undergoing right heart catheterization will be investigated by thoracic CT and special software to determine morphologic readouts.

The investigators expect that using this non-invasive method, parameters relevant for the differentiation of the patients with PH can be determined.

Detailed Description

Pulmonary hypertension (PH) is defined as an elevated mean pressure in the pulmonary artery above 20mmHg determined at right-heart catheterization. Depending on the presentation and pathogenesis, patients are classified according to five main groups. A correct classification is crucial, since it is essential for the available therapy options.

A promising non-invasive method to provide important hemodynamic and clinical Information is the fully-automatic analysis of thoracic computed tomography images. This method can yield a number of quantitative morphologic readouts of the lung vasculature and the parenchyma.

This study aims to identify quantitative markers from the fully-automatic image analysis, which allow a discrimination between the various PH patient groups.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
23
Inclusion Criteria
  • Patients with right-heart catheterization
  • Clinical indication for thoracic CT
Exclusion Criteria
  • Pregnancy
  • Decreased kidney function
  • Intolerance to contrast material
  • Other standard CT contraindications

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Chronic thromboembolic pulmonary hypertension (CTEPH)Thoracic computed tomographyThe patients with CTEPH received an invasive right-heart catheterization and a thoracic CT scan as part of their routine work up.
PH due to emphysema (PH-LD-Emphys)Thoracic computed tomographyThe patients with PH-LD-Emphys received an invasive right-heart catheterization and a thoracic CT scan as part of their routine work up.
PH due to left-heart disease (PH-LHD)Thoracic computed tomographyThe patients with PH-LHD received an invasive right-heart catheterization and a thoracic CT scan as part of their routine work up.
PH due to combined emphysema and fibrosis (PH-LD-CPFE)Thoracic computed tomographyThe patients with PH-LD-CPFE received an invasive right-heart catheterization and a thoracic CT scan as part of their routine work up.
Pulmonary arterial hypertension (PAH)Thoracic computed tomographyThe patients with PAH received an invasive right-heart catheterization and a thoracic CT scan as part of their routine work up.
PH due to lung fibrosis (PH-LD-Fibr)Thoracic computed tomographyThe patients with PH-LD-Fibr received an invasive right-heart catheterization and a thoracic CT scan as part of their routine work up.
No PHThoracic computed tomographyThe patients without PH received an invasive right-heart catheterization and a thoracic CT scan as part of their routine work up.
Primary Outcome Measures
NameTimeMethod
Lung vessel morphology1 day

Quantitative measures of lung vessel morphology based on automated CT image analysis based on artery-vein separation and vessel segmentation, which allow differentiation between the different groups of PH

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Medical University Graz, Division of Pulmonology

🇦🇹

Graz, Steiermark, Austria

© Copyright 2025. All Rights Reserved by MedPath